Sarah J. Alexander
Keine laufenden Positionen mehr
Profil
Sarah J.
Alexander served as an Independent Director at NewLink Genetics Corp.
from 2012 to 2012.
Prior to that, she obtained a doctorate degree from Emory University.
Ehemalige bekannte Positionen von Sarah J. Alexander
| Unternehmen | Position | Ende |
|---|---|---|
| LUMOS PHARMA, INC. | Direktor/Vorstandsmitglied | 02.11.2012 |
Ausbildung von Sarah J. Alexander
| Emory University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
